Evaluation of oxidative stress after repeated intravenous iron supplementation

Renal Failure

Volumn 27, Issue 3, 2005, Pages 345-351

  Mimić Oka, Jasmina ^a   Savic Radojevic A ^a   Pljesa Ercegovac M ^a   Opacic M ^a   Simic T ^a   Dimkovic N ^b   Simic D V ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute for Renal Diseases Zvezdara   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Anemia; Antioxidant enzymes; Chronic renal failure; Iron supplementation; Oxidative stress; Transferrin saturation

Indexed keywords

ANTIOXIDANT; CARBONYL DERIVATIVE; FERRIC GLUCONATE; FERRITIN; FREE RADICAL; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; IRON; MALONALDEHYDE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; SUPEROXIDE DISMUTASE; THIOL GROUP;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; ENZYME ANALYSIS; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON THERAPY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 20044363310     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1081/JDI-200056599     Document Type: Article

References (31)

1. Fisher, J.W. Mechanism of the anemia of chronic renal failure. Nephron 1980, 25, 106-111.
2. Eschenbach, J.W.; Adamson, J.W. Anemia of end stage renal disease (ESRD). Kidney Int. 1985, 28, 1-5.
3. Eckardt, K.U. Pathophysiology of renal anemia. Clin. Nephrol. 2000, 53 (S1), S2-S8.
4. Fishbane, S.; Frei, G.L.; Maesuka, J. Reduction of human erythropoietin dose by the use of chronic intravenous iron supplementation. Am. J. Kidney Dis. 1995, 7, 204-207.
5. Tarng, D.C.; Chen, T.W.; Huang, T.P. Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients. Am. J Nephrol. 1995, 15, 230-237.
6. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Clinical guide lines for the treatment of anemia of chronic renal failure. Eknoyan G., Ed.; III Iron support. Am. J. Kidney Dis. 1997, 30 (4 Suppl 3), S192-S240.
7. Deicher, R.; Horl, W.H. Intravenous iron: the iatrogenic kick to lose control over oxygen? Kidney Blood Press. Res. 2002, 25 (5), 284-288.
8. Mimic-Oka, J.; Simic, T.; Djukanovic, Lj.; Stefanovski; Ramie, Z. Glutathione and its associated enzymes in peripheral blood cells in different stages of chronic renal insufficiency. Amino Acids 1992, 2, 215-224.
9. Mimic-Oka, J.; Simic, T.; Ekmescic, V.; Dragicevic, P. Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure. Clin. Nephrol. 1995, 44 (1), 44-48.
10. Mimic-Oka, J.; Simic, T.; Djukanovic, Lj.; Reljic, Z.; Davicevic, Z. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin. Nephrol. 1999, 4, 223-241.
11. Jackson, P.; Loughrey, C.M.; Lightbody, J.H.; Mc Namel, P.T.; Young, I.S. Effects of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin. Chem. 1995, 41, 1135-1138.
12. Tetta, C.; Biasoli, S.; Schiavon, R.; Inguaggiato, P.; David, S.; Panichi, V.; Wratten, M.L. An overview of hemodialysis and oxidant stress. Blood Purif. 1999, 17, 118-126.
13. Luciak, M.; Trznadel, K. Free oxygen species metabolism during hemodialysis with different membranes. Nephrol. Dial. Transplant. 1991, S3, 66-70.
14. Grune, T.; Sommerburg, O.; Siems, W.G. Oxidative stress in anemia. Clin. Nephrol. 2000, 53 (S1), S18-S23.
15. Halliwell, B.; Gutteridge, J.M.C. Oxidative stress and antioxidant protection: some special cases. In Free Radicals in Biology and Medicine; Halliwell, B., Gutteridge, J.M.C., Eds.; Oxford University Press: New York, 2000; 485-499.
16. Ludat, K.; Sommerburg, O.; Grune, T.; Siems, W.G.; Riedel; Hampl, H. Oxidation parameters in complete correction of renal anemia. Clin. Nephrol. 2000, 53 (S1), 530-535.
17. Mimic-Oka, J.; Simic, T.; Djukanovic, Lj. Epoetin treatment improves red blood cell and plasma antioxidant capacity in hemodialysis patients. Ren. Fail. 2002, 24 (1), 77-87.
18. Lim, P.S.; Wei, Y.H.; Yu, Y.L.; Kho, B. Enhanced oxidative stress in hemodialysis patients receiving intravenous iron therapy. Nephrol. Dial. Transplant. 1999, 14, 2680-2687.
19. Rooyakkers, T.M.; Stroes, E.S.; Kooistra, M.P.; van Faassen, E.E.; Hider, R.C.; Rabelink, T.J.; Marx, J.J. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur. J. Clin. Investig. 2002, S1, 9-16.
20. Misra, H.P.; Fridovich, I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 1972, 247, 3170-3175.
21. Gunzler, W.A.; Kremers, H.; Flohe, L. An improved coupled test procedure for glutathione peroxidase in blood. Z. Klin. Chem. Klin. Biochem. 1974, 12, 444-448.
22. Dousset, J.C.; Trouilh, M.; Foglietti, M.J. Plasma malonaldehyde levels during myocardial infarction. Clin. Chim. Acta 1983, 129, 319-322.
23. Jocelyn, P.C. Spectrophotometric assay of thiols. Methods Enzymol. 1987, 143, 44-67.
24. Elman, G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 74, 443-450.
25. Levine, R.L.; Williams, J.A.; Stadtman, E.R.; Shacter, E. Carbonyl assay determination of oxidatively modified proteins. Methods Enzymol. 1994, 233, 346-357.
26. Cavdar, C.; Temiz, A.; Yenicerioglu; Caliskan, S.; Celik, A.; Sifil, A.; Onvural, B.; Camsari, T. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients. Scand. J. Urol. Nephrol. 2003, 37 (1), 77-82.
27. Tovbin, D.; Mazor, D.; Vorobiov, M.; Chaimovitz, C.; Meyerstein, N. Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation. Am. J. Kidney Dis. 2002, 40 (5), 1005-1012.
28. Drücke, T.; Witko-Sarsat, V.; Massy, Z.; Descamps-Latscha, B.; Guerrin, A.P.; Marchais, S.J.; Gausson, V.; London, G.M. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002, 106, 2212-2217.
29. Roob, J.M.; Koschsorur, G.; Tiran, A.; Horina, J.H.; Holzer, H.; Winklhofer-Roob, B.M. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J. Am. Soc. Nephrol. 2000, 11, 539-549.
30. Esposito, B.P.; Breuer, W.; Slotki, I.; Cabantchik, Z.I. Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients. Eur. J. Clin. Investig. 2002, 32 (S1), 42-49.
31. Davies, K.J.A. Protein damage and degradation by oxygen free radicals. II Modification of amino acids. J. Biol. Chem. 1987, 262, 9902-9907.